Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour first dose of Mounjaro can be taken on any day of the week, but the day you choose becomes your weekly injection day going forward, so it is worth picking one that fits your routine. Mounjaro (tirzepatide) is a prescription-only medicine, and a GPhC-registered prescriber will confirm the exact timing as part of your clinical assessment. Once that is in place, the practical decisions are yours to manage. Most people find the first pen less daunting than they expected — it arrives in plain, unbranded packaging via DPD with tracking, and the KwikPen itself is designed to be straightforward to use. Read the Patient Information Leaflet inside your pack before you begin; it covers everything your prescriber wants you to know about the first injection and what to do next.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
In short: no, but choose carefully because you are committing to that day. Mounjaro is injected once a week, and your body's exposure to tirzepatide depends on that seven-day rhythm staying consistent. If you start on a Tuesday, every subsequent dose should fall on a Tuesday. There is no clinical reason to prefer a Monday over a Friday, but practical reasons are real. A weekend day suits some people because they are at home and calm; a midweek day suits others because they have a regular routine. Think about which day you are least likely to be travelling, stressed or otherwise distracted.
One detail worth knowing: doses can be shifted by up to two days in either direction if a clash is unavoidable, provided the gap between injections is still at least four days. Your prescriber will explain this during your consultation, and the NHS tirzepatide patient information page covers missed and shifted doses in plain language.
Whatever day you choose, note it down somewhere. A simple phone reminder set to repeat weekly is all most people need. That regularity is genuinely helpful once your doses begin to increase through the titration schedule.
Mounjaro can be injected at any time of day. Unlike some medicines, it does not need to be taken on an empty stomach, and it is not affected by food or drink timing in the way that, for example, the oral semaglutide tablet requires a strict fasting window. Morning, lunchtime and evening are all used by patients in clinical trials and in practice.
That said, some people find that injecting in the morning on an empty stomach before breakfast gives them useful information in those early weeks: if nausea does occur, it tends to arrive within a few hours of the injection, so a morning dose means any discomfort passes well before the evening. Others prefer evening so that any early nausea coincides with sleep. Neither strategy is clinically superior; it is personal preference.
The thing that matters most is that whatever time you choose for your first Mounjaro dose, you repeat it each week. Nausea and other gastrointestinal effects are most common after starting or after a dose increase, and they typically settle within a few days to two weeks as your body adjusts. Keeping a consistent time helps you track your pattern and spot anything worth discussing with your prescriber.
The first dose follows exactly the same injection technique as every dose that follows. Mounjaro is injected into subcutaneous fat (the soft tissue just beneath the skin) at one of three sites: the abdomen, the thigh or the upper arm. You rotate the site with each injection to avoid skin irritation building up in one area, so it is sensible to decide on a rotation order before you begin.
For many first-time injectors, the abdomen is the easiest site to reach and see. Clean the skin with an alcohol swab, let it dry, and follow the step-by-step instructions in the Patient Information Leaflet that arrives with your pen. The KwikPen mechanism means you do not need to draw up a dose or handle a needle directly. You will hear and feel a click; hold the pen in place for the seconds stated in the leaflet, then dispose of the pen safely in a sharps container.
The full guide to injection technique for your first dose walks through each step in detail. Storage before you inject matters too: the pen should be kept refrigerated at 2–8°C right up until you use it. If you want a complete walkthrough of what taking your first dose of Mounjaro involves from start to finish, that guide covers everything from preparation through to aftercare. The exact window for keeping it at room temperature before injection is specified in the leaflet, check there rather than relying on general guidance, because the rules are more precise than most people expect.
For most people, the first dose at 2.5mg passes with very little drama. The starter dose is set deliberately low to let your system adjust before the therapeutic doses that come later in the titration schedule. Some people notice mild nausea or a reduced appetite in the first day or two; others feel nothing different at all. Neither outcome is a sign that the treatment is or is not working.
Common early side effects are gastrointestinal: nausea, loose stools, reduced appetite, and occasionally some indigestion. These are well documented, the NHS patient information for tirzepatide lists them clearly and explains when they typically occur. They tend to be mild at the starting dose and more noticeable after dose increases.
What should prompt you to contact a prescriber promptly is severe, persistent abdominal pain, especially pain that radiates toward the back, with or without vomiting. That pattern can indicate acute pancreatitis, which the MHRA highlighted in a Drug Safety Update in January 2026 as a known, infrequent but serious risk with GLP-1 medicines. For broader questions about how results develop after the first few weeks, the page on how long the first dose takes to work is a good next read. Many people also find it helpful to understand when to take the golden dose of Mounjaro, particularly as they move further into the titration schedule. And if you have questions about costs before you begin, our Mounjaro pricing page explains exactly what a private prescription through a regulated pharmacy includes. A gentle close: if you have not yet had a clinical assessment, our prescribers can review your consultation the same day you complete it, start your free consultation here.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.